The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| FIDUS INVT CORP | COM | 316500107 | 3,803 | 260,105 | SH | SOLE | 0 | 260,105 | 0 | 0 | |
| ALPHATEC HOLDINGS INC | COM NEW | 02081G201 | 141 | 41,977 | SH | SOLE | 0 | 41,977 | 0 | 0 | |
| NOVOCURE LTD | ORD SHS | G6674U108 | 21,771 | 415,479 | SH | SOLE | 0 | 415,479 | 0 | 0 | |
| ATHENE HLDG LTD | CL A | G0684D107 | 74,527 | 1,442,640 | SH | SOLE | 0 | 1,442,640 | 0 | 0 | |